Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
20
IYH Quote, Financials, Valuation and Earnings
Last price:
$58.30
Seasonality move
:
0.6%
Day range:
$58.00 - $58.81
52-week range:
$56.44 - $66.59
Dividend yield:
1.25%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
513.2K
Avg. volume:
386.9K
1-year change:
4.75%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | -- | -- | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | -- | -- | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IYH
iShares US Healthcare ETF
|
$58.30 | -- | -- | -- | $0.20 | 1.25% | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
$65.41 | -- | -- | -- | $0.26 | 1.51% | -- |
|
IBB
iShares Biotechnology ETF
|
$132.73 | -- | -- | -- | $0.06 | 0.29% | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
$65.71 | -- | -- | -- | $0.21 | 1.73% | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
$253.89 | -- | -- | -- | $0.92 | 1.52% | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
$138.00 | -- | -- | -- | $0.58 | 1.65% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IYH
iShares US Healthcare ETF
|
-- | 0.983 | -- | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | 1.049 | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | 1.446 | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | 1.040 | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | 1.066 | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | 0.981 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | -- | -- | -- | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | -- | -- | -- | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | -- | -- | -- | -- | -- |
iShares US Healthcare ETF vs. Competitors
-
Which has Higher Returns IYH or FHLC?
Fidelity MSCI Health Care Index ETF has a net margin of -- compared to iShares US Healthcare ETF's net margin of --. iShares US Healthcare ETF's return on equity of -- beat Fidelity MSCI Health Care Index ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IYHiShares US Healthcare ETF-- -- -- FHLCFidelity MSCI Health Care Index ETF-- -- -- -
What do Analysts Say About IYH or FHLC?
iShares US Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Fidelity MSCI Health Care Index ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Healthcare ETF has higher upside potential than Fidelity MSCI Health Care Index ETF, analysts believe iShares US Healthcare ETF is more attractive than Fidelity MSCI Health Care Index ETF.
Company Buy Ratings Hold Ratings Sell Ratings IYHiShares US Healthcare ETF0 0 0 FHLCFidelity MSCI Health Care Index ETF0 0 0 -
Is IYH or FHLC More Risky?
iShares US Healthcare ETF has a beta of 0.685, which suggesting that the stock is 31.453% less volatile than S&P 500. In comparison Fidelity MSCI Health Care Index ETF has a beta of 0.703, suggesting its less volatile than the S&P 500 by 29.734%.
-
Which is a Better Dividend Stock IYH or FHLC?
iShares US Healthcare ETF has a quarterly dividend of $0.20 per share corresponding to a yield of 1.25%. Fidelity MSCI Health Care Index ETF offers a yield of 1.51% to investors and pays a quarterly dividend of $0.26 per share. iShares US Healthcare ETF pays -- of its earnings as a dividend. Fidelity MSCI Health Care Index ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IYH or FHLC?
iShares US Healthcare ETF quarterly revenues are --, which are smaller than Fidelity MSCI Health Care Index ETF quarterly revenues of --. iShares US Healthcare ETF's net income of -- is lower than Fidelity MSCI Health Care Index ETF's net income of --. Notably, iShares US Healthcare ETF's price-to-earnings ratio is -- while Fidelity MSCI Health Care Index ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Healthcare ETF is -- versus -- for Fidelity MSCI Health Care Index ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IYHiShares US Healthcare ETF-- -- -- -- FHLCFidelity MSCI Health Care Index ETF-- -- -- --
-
Which has Higher Returns IYH or IBB?
iShares Biotechnology ETF has a net margin of -- compared to iShares US Healthcare ETF's net margin of --. iShares US Healthcare ETF's return on equity of -- beat iShares Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IYHiShares US Healthcare ETF-- -- -- IBBiShares Biotechnology ETF-- -- -- -
What do Analysts Say About IYH or IBB?
iShares US Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Healthcare ETF has higher upside potential than iShares Biotechnology ETF, analysts believe iShares US Healthcare ETF is more attractive than iShares Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings IYHiShares US Healthcare ETF0 0 0 IBBiShares Biotechnology ETF0 0 0 -
Is IYH or IBB More Risky?
iShares US Healthcare ETF has a beta of 0.685, which suggesting that the stock is 31.453% less volatile than S&P 500. In comparison iShares Biotechnology ETF has a beta of 0.740, suggesting its less volatile than the S&P 500 by 26.046%.
-
Which is a Better Dividend Stock IYH or IBB?
iShares US Healthcare ETF has a quarterly dividend of $0.20 per share corresponding to a yield of 1.25%. iShares Biotechnology ETF offers a yield of 0.29% to investors and pays a quarterly dividend of $0.06 per share. iShares US Healthcare ETF pays -- of its earnings as a dividend. iShares Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IYH or IBB?
iShares US Healthcare ETF quarterly revenues are --, which are smaller than iShares Biotechnology ETF quarterly revenues of --. iShares US Healthcare ETF's net income of -- is lower than iShares Biotechnology ETF's net income of --. Notably, iShares US Healthcare ETF's price-to-earnings ratio is -- while iShares Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Healthcare ETF is -- versus -- for iShares Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IYHiShares US Healthcare ETF-- -- -- -- IBBiShares Biotechnology ETF-- -- -- --
-
Which has Higher Returns IYH or IHE?
iShares US Pharmaceuticals ETF has a net margin of -- compared to iShares US Healthcare ETF's net margin of --. iShares US Healthcare ETF's return on equity of -- beat iShares US Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IYHiShares US Healthcare ETF-- -- -- IHEiShares US Pharmaceuticals ETF-- -- -- -
What do Analysts Say About IYH or IHE?
iShares US Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Healthcare ETF has higher upside potential than iShares US Pharmaceuticals ETF, analysts believe iShares US Healthcare ETF is more attractive than iShares US Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings IYHiShares US Healthcare ETF0 0 0 IHEiShares US Pharmaceuticals ETF0 0 0 -
Is IYH or IHE More Risky?
iShares US Healthcare ETF has a beta of 0.685, which suggesting that the stock is 31.453% less volatile than S&P 500. In comparison iShares US Pharmaceuticals ETF has a beta of 0.656, suggesting its less volatile than the S&P 500 by 34.431%.
-
Which is a Better Dividend Stock IYH or IHE?
iShares US Healthcare ETF has a quarterly dividend of $0.20 per share corresponding to a yield of 1.25%. iShares US Pharmaceuticals ETF offers a yield of 1.73% to investors and pays a quarterly dividend of $0.21 per share. iShares US Healthcare ETF pays -- of its earnings as a dividend. iShares US Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IYH or IHE?
iShares US Healthcare ETF quarterly revenues are --, which are smaller than iShares US Pharmaceuticals ETF quarterly revenues of --. iShares US Healthcare ETF's net income of -- is lower than iShares US Pharmaceuticals ETF's net income of --. Notably, iShares US Healthcare ETF's price-to-earnings ratio is -- while iShares US Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Healthcare ETF is -- versus -- for iShares US Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IYHiShares US Healthcare ETF-- -- -- -- IHEiShares US Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns IYH or VHT?
Vanguard Health Care Index Fund ETF has a net margin of -- compared to iShares US Healthcare ETF's net margin of --. iShares US Healthcare ETF's return on equity of -- beat Vanguard Health Care Index Fund ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IYHiShares US Healthcare ETF-- -- -- VHTVanguard Health Care Index Fund ETF-- -- -- -
What do Analysts Say About IYH or VHT?
iShares US Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Vanguard Health Care Index Fund ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Healthcare ETF has higher upside potential than Vanguard Health Care Index Fund ETF, analysts believe iShares US Healthcare ETF is more attractive than Vanguard Health Care Index Fund ETF.
Company Buy Ratings Hold Ratings Sell Ratings IYHiShares US Healthcare ETF0 0 0 VHTVanguard Health Care Index Fund ETF0 0 0 -
Is IYH or VHT More Risky?
iShares US Healthcare ETF has a beta of 0.685, which suggesting that the stock is 31.453% less volatile than S&P 500. In comparison Vanguard Health Care Index Fund ETF has a beta of 0.708, suggesting its less volatile than the S&P 500 by 29.236%.
-
Which is a Better Dividend Stock IYH or VHT?
iShares US Healthcare ETF has a quarterly dividend of $0.20 per share corresponding to a yield of 1.25%. Vanguard Health Care Index Fund ETF offers a yield of 1.52% to investors and pays a quarterly dividend of $0.92 per share. iShares US Healthcare ETF pays -- of its earnings as a dividend. Vanguard Health Care Index Fund ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IYH or VHT?
iShares US Healthcare ETF quarterly revenues are --, which are smaller than Vanguard Health Care Index Fund ETF quarterly revenues of --. iShares US Healthcare ETF's net income of -- is lower than Vanguard Health Care Index Fund ETF's net income of --. Notably, iShares US Healthcare ETF's price-to-earnings ratio is -- while Vanguard Health Care Index Fund ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Healthcare ETF is -- versus -- for Vanguard Health Care Index Fund ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IYHiShares US Healthcare ETF-- -- -- -- VHTVanguard Health Care Index Fund ETF-- -- -- --
-
Which has Higher Returns IYH or XLV?
Health Care Select Sector SPDR Fund has a net margin of -- compared to iShares US Healthcare ETF's net margin of --. iShares US Healthcare ETF's return on equity of -- beat Health Care Select Sector SPDR Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IYHiShares US Healthcare ETF-- -- -- XLVHealth Care Select Sector SPDR Fund-- -- -- -
What do Analysts Say About IYH or XLV?
iShares US Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Health Care Select Sector SPDR Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Healthcare ETF has higher upside potential than Health Care Select Sector SPDR Fund, analysts believe iShares US Healthcare ETF is more attractive than Health Care Select Sector SPDR Fund.
Company Buy Ratings Hold Ratings Sell Ratings IYHiShares US Healthcare ETF0 0 0 XLVHealth Care Select Sector SPDR Fund0 0 0 -
Is IYH or XLV More Risky?
iShares US Healthcare ETF has a beta of 0.685, which suggesting that the stock is 31.453% less volatile than S&P 500. In comparison Health Care Select Sector SPDR Fund has a beta of 0.672, suggesting its less volatile than the S&P 500 by 32.764%.
-
Which is a Better Dividend Stock IYH or XLV?
iShares US Healthcare ETF has a quarterly dividend of $0.20 per share corresponding to a yield of 1.25%. Health Care Select Sector SPDR Fund offers a yield of 1.65% to investors and pays a quarterly dividend of $0.58 per share. iShares US Healthcare ETF pays -- of its earnings as a dividend. Health Care Select Sector SPDR Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IYH or XLV?
iShares US Healthcare ETF quarterly revenues are --, which are smaller than Health Care Select Sector SPDR Fund quarterly revenues of --. iShares US Healthcare ETF's net income of -- is lower than Health Care Select Sector SPDR Fund's net income of --. Notably, iShares US Healthcare ETF's price-to-earnings ratio is -- while Health Care Select Sector SPDR Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Healthcare ETF is -- versus -- for Health Care Select Sector SPDR Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IYHiShares US Healthcare ETF-- -- -- -- XLVHealth Care Select Sector SPDR Fund-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
